ERBB2 and breast carcinoma: Additionally, we point out that, in the near future, a fast diagnostic kit to identify serum protein expression levels in cats with mammary carcinomas may become available, e.g., in the HER2-positive subtype, one of the most aggressive tumors [17], which would allow prediction of prognosis and inform the choice of therapeutic protocol.